{"transactions":[{"id":710795,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":30865,"kind":"person","name":"Almstead Neil Gregory","position":1,"cik":"0001578850","reported_name":"Almstead Neil Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPS OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-13T21:20:05.000Z","date":"2026-07-09","kind":"exercise","planned":true,"acquired":false,"shares":2464,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on January 3, 2025, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2026, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2026."}],"balance_after":45036,"derivative":{"exercise_price":46.54,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":2464},"source":{"system":"sec-edgar","filing":"0001578850-26-000023","document":"form4-07132026_050701.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885026000023/form4-07132026_050701.xml","form_type":"4"}},{"id":710794,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":30865,"kind":"person","name":"Almstead Neil Gregory","position":1,"cik":"0001578850","reported_name":"Almstead Neil Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPS OFFICER"}}],"security":"Common Stock","published_at":"2026-07-13T21:20:05.000Z","date":"2026-07-09","kind":"sale","planned":true,"acquired":false,"shares":2464,"price":90.25,"value":222376.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $90.00 to $90.70 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":60299,"source":{"system":"sec-edgar","filing":"0001578850-26-000023","document":"form4-07132026_050701.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885026000023/form4-07132026_050701.xml","form_type":"4"}},{"id":710793,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":30865,"kind":"person","name":"Almstead Neil Gregory","position":1,"cik":"0001578850","reported_name":"Almstead Neil Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPS OFFICER"}}],"security":"Common Stock","published_at":"2026-07-13T21:20:05.000Z","date":"2026-07-09","kind":"exercise","planned":true,"acquired":true,"shares":2464,"price":46.54,"value":114674.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025."}],"balance_after":62763,"source":{"system":"sec-edgar","filing":"0001578850-26-000023","document":"form4-07132026_050701.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885026000023/form4-07132026_050701.xml","form_type":"4"}},{"id":713035,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":30865,"kind":"person","name":"Almstead Neil Gregory","position":1,"cik":"0001578850","reported_name":"Almstead Neil Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPS OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-08T21:20:06.000Z","date":"2026-07-07","kind":"exercise","planned":true,"acquired":false,"shares":24613,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"This option was granted on January 5, 2023, and vests over four years, with 25% of the shares underlying the option vesting on January 5, 2024, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 5, 2024."}],"balance_after":9063,"derivative":{"exercise_price":39.42,"expiration_date":"2033-01-04","underlying":"Common Stock","underlying_shares":24613},"source":{"system":"sec-edgar","filing":"0001578850-26-000021","document":"form4-07082026_050702.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885026000021/form4-07082026_050702.xml","form_type":"4"}},{"id":713034,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":30865,"kind":"person","name":"Almstead Neil Gregory","position":1,"cik":"0001578850","reported_name":"Almstead Neil Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPS OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-08T21:20:06.000Z","date":"2026-07-06","kind":"exercise","planned":true,"acquired":false,"shares":2474,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"This option was granted on January 5, 2023, and vests over four years, with 25% of the shares underlying the option vesting on January 5, 2024, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 5, 2024."}],"balance_after":33676,"derivative":{"exercise_price":39.42,"expiration_date":"2033-01-04","underlying":"Common Stock","underlying_shares":2474},"source":{"system":"sec-edgar","filing":"0001578850-26-000021","document":"form4-07082026_050702.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885026000021/form4-07082026_050702.xml","form_type":"4"}},{"id":713033,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":30865,"kind":"person","name":"Almstead Neil Gregory","position":1,"cik":"0001578850","reported_name":"Almstead Neil Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPS OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-08T21:20:06.000Z","date":"2026-07-06","kind":"exercise","planned":true,"acquired":false,"shares":18876,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"Currently exercisable."}],"balance_after":0,"derivative":{"exercise_price":38.1,"expiration_date":"2032-01-06","underlying":"Common Stock","underlying_shares":18876},"source":{"system":"sec-edgar","filing":"0001578850-26-000021","document":"form4-07082026_050702.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885026000021/form4-07082026_050702.xml","form_type":"4"}},{"id":713032,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":30865,"kind":"person","name":"Almstead Neil Gregory","position":1,"cik":"0001578850","reported_name":"Almstead Neil Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPS OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-08T21:20:06.000Z","date":"2026-07-06","kind":"exercise","planned":true,"acquired":false,"shares":811,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"Currently exercisable."}],"balance_after":18876,"derivative":{"exercise_price":38.1,"expiration_date":"2032-01-06","underlying":"Common Stock","underlying_shares":811},"source":{"system":"sec-edgar","filing":"0001578850-26-000021","document":"form4-07082026_050702.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885026000021/form4-07082026_050702.xml","form_type":"4"}},{"id":713031,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":30865,"kind":"person","name":"Almstead Neil Gregory","position":1,"cik":"0001578850","reported_name":"Almstead Neil Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPS OFFICER"}}],"security":"Common Stock","published_at":"2026-07-08T21:20:06.000Z","date":"2026-07-07","kind":"sale","planned":true,"acquired":false,"shares":9288,"price":89.44,"value":830718.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $89.29 to $89.75 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":60299,"source":{"system":"sec-edgar","filing":"0001578850-26-000021","document":"form4-07082026_050702.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885026000021/form4-07082026_050702.xml","form_type":"4"}},{"id":713030,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":30865,"kind":"person","name":"Almstead Neil Gregory","position":1,"cik":"0001578850","reported_name":"Almstead Neil Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPS OFFICER"}}],"security":"Common Stock","published_at":"2026-07-08T21:20:06.000Z","date":"2026-07-07","kind":"sale","planned":true,"acquired":false,"shares":11369,"price":89.03,"value":1012182.07,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $88.29 to $89.28 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":69587,"source":{"system":"sec-edgar","filing":"0001578850-26-000021","document":"form4-07082026_050702.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885026000021/form4-07082026_050702.xml","form_type":"4"}},{"id":713029,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":30865,"kind":"person","name":"Almstead Neil Gregory","position":1,"cik":"0001578850","reported_name":"Almstead Neil Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPS OFFICER"}}],"security":"Common Stock","published_at":"2026-07-08T21:20:06.000Z","date":"2026-07-07","kind":"sale","planned":true,"acquired":false,"shares":3956,"price":87.17,"value":344844.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $87.00 to $87.81 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":80956,"source":{"system":"sec-edgar","filing":"0001578850-26-000021","document":"form4-07082026_050702.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885026000021/form4-07082026_050702.xml","form_type":"4"}},{"id":713028,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":30865,"kind":"person","name":"Almstead Neil Gregory","position":1,"cik":"0001578850","reported_name":"Almstead Neil Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPS OFFICER"}}],"security":"Common Stock","published_at":"2026-07-08T21:20:06.000Z","date":"2026-07-07","kind":"exercise","planned":true,"acquired":true,"shares":24613,"price":39.42,"value":970244.46,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025."}],"balance_after":84912,"source":{"system":"sec-edgar","filing":"0001578850-26-000021","document":"form4-07082026_050702.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885026000021/form4-07082026_050702.xml","form_type":"4"}},{"id":713027,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":30865,"kind":"person","name":"Almstead Neil Gregory","position":1,"cik":"0001578850","reported_name":"Almstead Neil Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPS OFFICER"}}],"security":"Common Stock","published_at":"2026-07-08T21:20:06.000Z","date":"2026-07-06","kind":"sale","planned":true,"acquired":false,"shares":2474,"price":87.03,"value":215312.22,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $87.00 to $87.07 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":60299,"source":{"system":"sec-edgar","filing":"0001578850-26-000021","document":"form4-07082026_050702.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885026000021/form4-07082026_050702.xml","form_type":"4"}},{"id":713026,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":30865,"kind":"person","name":"Almstead Neil Gregory","position":1,"cik":"0001578850","reported_name":"Almstead Neil Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPS OFFICER"}}],"security":"Common Stock","published_at":"2026-07-08T21:20:06.000Z","date":"2026-07-06","kind":"exercise","planned":true,"acquired":true,"shares":2474,"price":39.42,"value":97525.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025."}],"balance_after":62773,"source":{"system":"sec-edgar","filing":"0001578850-26-000021","document":"form4-07082026_050702.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885026000021/form4-07082026_050702.xml","form_type":"4"}},{"id":713025,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":30865,"kind":"person","name":"Almstead Neil Gregory","position":1,"cik":"0001578850","reported_name":"Almstead Neil Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPS OFFICER"}}],"security":"Common Stock","published_at":"2026-07-08T21:20:06.000Z","date":"2026-07-06","kind":"sale","planned":true,"acquired":false,"shares":10090,"price":86.32,"value":870968.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $86.03 to $86.74 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":60299,"source":{"system":"sec-edgar","filing":"0001578850-26-000021","document":"form4-07082026_050702.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885026000021/form4-07082026_050702.xml","form_type":"4"}},{"id":713024,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":30865,"kind":"person","name":"Almstead Neil Gregory","position":1,"cik":"0001578850","reported_name":"Almstead Neil Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPS OFFICER"}}],"security":"Common Stock","published_at":"2026-07-08T21:20:06.000Z","date":"2026-07-06","kind":"sale","planned":true,"acquired":false,"shares":8786,"price":85.35,"value":749885.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $85.00 to $85.98 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":70389,"source":{"system":"sec-edgar","filing":"0001578850-26-000021","document":"form4-07082026_050702.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885026000021/form4-07082026_050702.xml","form_type":"4"}},{"id":713023,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":30865,"kind":"person","name":"Almstead Neil Gregory","position":1,"cik":"0001578850","reported_name":"Almstead Neil Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPS OFFICER"}}],"security":"Common Stock","published_at":"2026-07-08T21:20:06.000Z","date":"2026-07-06","kind":"exercise","planned":true,"acquired":true,"shares":18876,"price":38.1,"value":719175.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025."}],"balance_after":79175,"source":{"system":"sec-edgar","filing":"0001578850-26-000021","document":"form4-07082026_050702.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885026000021/form4-07082026_050702.xml","form_type":"4"}},{"id":713022,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":30865,"kind":"person","name":"Almstead Neil Gregory","position":1,"cik":"0001578850","reported_name":"Almstead Neil Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPS OFFICER"}}],"security":"Common Stock","published_at":"2026-07-08T21:20:06.000Z","date":"2026-07-06","kind":"sale","planned":true,"acquired":false,"shares":385,"price":86.34,"value":33240.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $86.02 to $86.73 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":60299,"source":{"system":"sec-edgar","filing":"0001578850-26-000021","document":"form4-07082026_050702.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885026000021/form4-07082026_050702.xml","form_type":"4"}},{"id":713021,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":30865,"kind":"person","name":"Almstead Neil Gregory","position":1,"cik":"0001578850","reported_name":"Almstead Neil Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPS OFFICER"}}],"security":"Common Stock","published_at":"2026-07-08T21:20:06.000Z","date":"2026-07-06","kind":"sale","planned":true,"acquired":false,"shares":426,"price":85.28,"value":36329.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $85.00 to $85.95 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":60684,"source":{"system":"sec-edgar","filing":"0001578850-26-000021","document":"form4-07082026_050702.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885026000021/form4-07082026_050702.xml","form_type":"4"}},{"id":713020,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":30865,"kind":"person","name":"Almstead Neil Gregory","position":1,"cik":"0001578850","reported_name":"Almstead Neil Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPS OFFICER"}}],"security":"Common Stock","published_at":"2026-07-08T21:20:06.000Z","date":"2026-07-06","kind":"exercise","planned":true,"acquired":true,"shares":811,"price":38.1,"value":30899.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 162 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ended June 30, 2026."}],"balance_after":61110,"source":{"system":"sec-edgar","filing":"0001578850-26-000021","document":"form4-07082026_050702.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885026000021/form4-07082026_050702.xml","form_type":"4"}},{"id":723138,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":30865,"kind":"person","name":"Almstead Neil Gregory","position":1,"cik":"0001578850","reported_name":"Almstead Neil Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPS OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-30T21:20:08.000Z","date":"2026-06-26","kind":"exercise","planned":true,"acquired":false,"shares":7718,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Currently exercisable."}],"balance_after":19687,"derivative":{"exercise_price":38.1,"expiration_date":"2032-01-06","underlying":"Common Stock","underlying_shares":7718},"source":{"system":"sec-edgar","filing":"0001578850-26-000019","document":"form4-06302026_050601.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885026000019/form4-06302026_050601.xml","form_type":"4"}},{"id":723137,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":30865,"kind":"person","name":"Almstead Neil Gregory","position":1,"cik":"0001578850","reported_name":"Almstead Neil Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPS OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-30T21:20:08.000Z","date":"2026-06-26","kind":"exercise","planned":true,"acquired":false,"shares":412,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Currently exercisable."}],"balance_after":27405,"derivative":{"exercise_price":38.1,"expiration_date":"2032-01-06","underlying":"Common Stock","underlying_shares":412},"source":{"system":"sec-edgar","filing":"0001578850-26-000019","document":"form4-06302026_050601.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885026000019/form4-06302026_050601.xml","form_type":"4"}},{"id":723136,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":30865,"kind":"person","name":"Almstead Neil Gregory","position":1,"cik":"0001578850","reported_name":"Almstead Neil Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPS OFFICER"}}],"security":"Common Stock","published_at":"2026-06-30T21:20:08.000Z","date":"2026-06-26","kind":"sale","planned":true,"acquired":false,"shares":7718,"price":85.26,"value":658036.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $85.00 to $85.75 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":60137,"source":{"system":"sec-edgar","filing":"0001578850-26-000019","document":"form4-06302026_050601.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885026000019/form4-06302026_050601.xml","form_type":"4"}},{"id":723135,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":30865,"kind":"person","name":"Almstead Neil Gregory","position":1,"cik":"0001578850","reported_name":"Almstead Neil Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPS OFFICER"}}],"security":"Common Stock","published_at":"2026-06-30T21:20:08.000Z","date":"2026-06-26","kind":"exercise","planned":true,"acquired":true,"shares":7718,"price":38.1,"value":294055.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025."}],"balance_after":67855,"source":{"system":"sec-edgar","filing":"0001578850-26-000019","document":"form4-06302026_050601.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885026000019/form4-06302026_050601.xml","form_type":"4"}},{"id":723134,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":30865,"kind":"person","name":"Almstead Neil Gregory","position":1,"cik":"0001578850","reported_name":"Almstead Neil Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPS OFFICER"}}],"security":"Common Stock","published_at":"2026-06-30T21:20:08.000Z","date":"2026-06-26","kind":"sale","planned":true,"acquired":false,"shares":412,"price":85.23,"value":35114.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $85.07 to $85.30 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":60137,"source":{"system":"sec-edgar","filing":"0001578850-26-000019","document":"form4-06302026_050601.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885026000019/form4-06302026_050601.xml","form_type":"4"}},{"id":723133,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":30865,"kind":"person","name":"Almstead Neil Gregory","position":1,"cik":"0001578850","reported_name":"Almstead Neil Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPS OFFICER"}}],"security":"Common Stock","published_at":"2026-06-30T21:20:08.000Z","date":"2026-06-26","kind":"exercise","planned":true,"acquired":true,"shares":412,"price":38.1,"value":15697.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025."}],"balance_after":60549,"source":{"system":"sec-edgar","filing":"0001578850-26-000019","document":"form4-06302026_050601.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885026000019/form4-06302026_050601.xml","form_type":"4"}},{"id":725838,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":30865,"kind":"person","name":"Almstead Neil Gregory","position":1,"cik":"0001578850","reported_name":"Almstead Neil Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPS OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-26T21:20:05.000Z","date":"2026-06-25","kind":"exercise","planned":true,"acquired":false,"shares":100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"This option was granted on January 5, 2023, and vests over four years, with 25% of the shares underlying the option vesting on January 5, 2024, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 5, 2024."}],"balance_after":36150,"derivative":{"exercise_price":39.42,"expiration_date":"2033-01-04","underlying":"Common Stock","underlying_shares":100},"source":{"system":"sec-edgar","filing":"0001578850-26-000017","document":"form4-06262026_050601.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885026000017/form4-06262026_050601.xml","form_type":"4"}},{"id":725837,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":30865,"kind":"person","name":"Almstead Neil Gregory","position":1,"cik":"0001578850","reported_name":"Almstead Neil Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPS OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-26T21:20:05.000Z","date":"2026-06-25","kind":"exercise","planned":true,"acquired":false,"shares":19859,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Currently exercisable."}],"balance_after":27817,"derivative":{"exercise_price":38.1,"expiration_date":"2032-01-06","underlying":"Common Stock","underlying_shares":19859},"source":{"system":"sec-edgar","filing":"0001578850-26-000017","document":"form4-06262026_050601.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885026000017/form4-06262026_050601.xml","form_type":"4"}},{"id":725836,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":30865,"kind":"person","name":"Almstead Neil Gregory","position":1,"cik":"0001578850","reported_name":"Almstead Neil Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPS OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-26T21:20:05.000Z","date":"2026-06-25","kind":"exercise","planned":true,"acquired":false,"shares":1001,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Currently exercisable."}],"balance_after":47676,"derivative":{"exercise_price":38.1,"expiration_date":"2032-01-06","underlying":"Common Stock","underlying_shares":1001},"source":{"system":"sec-edgar","filing":"0001578850-26-000017","document":"form4-06262026_050601.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885026000017/form4-06262026_050601.xml","form_type":"4"}},{"id":725835,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":30865,"kind":"person","name":"Almstead Neil Gregory","position":1,"cik":"0001578850","reported_name":"Almstead Neil Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPS OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-26T21:20:05.000Z","date":"2026-06-24","kind":"exercise","planned":true,"acquired":false,"shares":4922,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Currently exercisable."}],"balance_after":48677,"derivative":{"exercise_price":38.1,"expiration_date":"2032-01-06","underlying":"Common Stock","underlying_shares":4922},"source":{"system":"sec-edgar","filing":"0001578850-26-000017","document":"form4-06262026_050601.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885026000017/form4-06262026_050601.xml","form_type":"4"}},{"id":725834,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":30865,"kind":"person","name":"Almstead Neil Gregory","position":1,"cik":"0001578850","reported_name":"Almstead Neil Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPS OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-26T21:20:05.000Z","date":"2026-06-24","kind":"exercise","planned":true,"acquired":false,"shares":401,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Currently exercisable."}],"balance_after":53599,"derivative":{"exercise_price":38.1,"expiration_date":"2032-01-06","underlying":"Common Stock","underlying_shares":401},"source":{"system":"sec-edgar","filing":"0001578850-26-000017","document":"form4-06262026_050601.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885026000017/form4-06262026_050601.xml","form_type":"4"}},{"id":725833,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":30865,"kind":"person","name":"Almstead Neil Gregory","position":1,"cik":"0001578850","reported_name":"Almstead Neil Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPS OFFICER"}}],"security":"Common Stock","published_at":"2026-06-26T21:20:05.000Z","date":"2026-06-25","kind":"sale","planned":true,"acquired":false,"shares":100,"price":87,"value":8700.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025."}],"balance_after":60137,"source":{"system":"sec-edgar","filing":"0001578850-26-000017","document":"form4-06262026_050601.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885026000017/form4-06262026_050601.xml","form_type":"4"}},{"id":725832,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":30865,"kind":"person","name":"Almstead Neil Gregory","position":1,"cik":"0001578850","reported_name":"Almstead Neil Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPS OFFICER"}}],"security":"Common Stock","published_at":"2026-06-26T21:20:05.000Z","date":"2026-06-25","kind":"exercise","planned":true,"acquired":true,"shares":100,"price":39.42,"value":3942.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025."}],"balance_after":60237,"source":{"system":"sec-edgar","filing":"0001578850-26-000017","document":"form4-06262026_050601.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885026000017/form4-06262026_050601.xml","form_type":"4"}},{"id":725831,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":30865,"kind":"person","name":"Almstead Neil Gregory","position":1,"cik":"0001578850","reported_name":"Almstead Neil Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPS OFFICER"}}],"security":"Common Stock","published_at":"2026-06-26T21:20:05.000Z","date":"2026-06-25","kind":"sale","planned":true,"acquired":false,"shares":11337,"price":86.51,"value":980763.87,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $86.02 to $86.97 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":60137,"source":{"system":"sec-edgar","filing":"0001578850-26-000017","document":"form4-06262026_050601.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885026000017/form4-06262026_050601.xml","form_type":"4"}},{"id":725830,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":30865,"kind":"person","name":"Almstead Neil Gregory","position":1,"cik":"0001578850","reported_name":"Almstead Neil Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPS OFFICER"}}],"security":"Common Stock","published_at":"2026-06-26T21:20:05.000Z","date":"2026-06-25","kind":"sale","planned":true,"acquired":false,"shares":8522,"price":85.26,"value":726585.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $85.00 to $85.98 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":71474,"source":{"system":"sec-edgar","filing":"0001578850-26-000017","document":"form4-06262026_050601.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885026000017/form4-06262026_050601.xml","form_type":"4"}},{"id":725829,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":30865,"kind":"person","name":"Almstead Neil Gregory","position":1,"cik":"0001578850","reported_name":"Almstead Neil Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPS OFFICER"}}],"security":"Common Stock","published_at":"2026-06-26T21:20:05.000Z","date":"2026-06-25","kind":"exercise","planned":true,"acquired":true,"shares":19859,"price":38.1,"value":756627.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025."}],"balance_after":79996,"source":{"system":"sec-edgar","filing":"0001578850-26-000017","document":"form4-06262026_050601.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885026000017/form4-06262026_050601.xml","form_type":"4"}},{"id":725828,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":30865,"kind":"person","name":"Almstead Neil Gregory","position":1,"cik":"0001578850","reported_name":"Almstead Neil Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPS OFFICER"}}],"security":"Common Stock","published_at":"2026-06-26T21:20:05.000Z","date":"2026-06-25","kind":"sale","planned":true,"acquired":false,"shares":419,"price":86.39,"value":36197.41,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $86.23 to $86.59 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":60137,"source":{"system":"sec-edgar","filing":"0001578850-26-000017","document":"form4-06262026_050601.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885026000017/form4-06262026_050601.xml","form_type":"4"}},{"id":725827,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":30865,"kind":"person","name":"Almstead Neil Gregory","position":1,"cik":"0001578850","reported_name":"Almstead Neil Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPS OFFICER"}}],"security":"Common Stock","published_at":"2026-06-26T21:20:05.000Z","date":"2026-06-25","kind":"sale","planned":true,"acquired":false,"shares":582,"price":85.24,"value":49609.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $85.00 to $85.84 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":60556,"source":{"system":"sec-edgar","filing":"0001578850-26-000017","document":"form4-06262026_050601.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885026000017/form4-06262026_050601.xml","form_type":"4"}},{"id":725826,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":30865,"kind":"person","name":"Almstead Neil Gregory","position":1,"cik":"0001578850","reported_name":"Almstead Neil Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPS OFFICER"}}],"security":"Common Stock","published_at":"2026-06-26T21:20:05.000Z","date":"2026-06-25","kind":"exercise","planned":true,"acquired":true,"shares":1001,"price":38.1,"value":38138.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025."}],"balance_after":61138,"source":{"system":"sec-edgar","filing":"0001578850-26-000017","document":"form4-06262026_050601.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885026000017/form4-06262026_050601.xml","form_type":"4"}},{"id":725825,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":30865,"kind":"person","name":"Almstead Neil Gregory","position":1,"cik":"0001578850","reported_name":"Almstead Neil Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPS OFFICER"}}],"security":"Common Stock","published_at":"2026-06-26T21:20:05.000Z","date":"2026-06-24","kind":"sale","planned":true,"acquired":false,"shares":4922,"price":85.03,"value":418517.66,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $85.00 to $85.14 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":60137,"source":{"system":"sec-edgar","filing":"0001578850-26-000017","document":"form4-06262026_050601.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885026000017/form4-06262026_050601.xml","form_type":"4"}},{"id":725824,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":30865,"kind":"person","name":"Almstead Neil Gregory","position":1,"cik":"0001578850","reported_name":"Almstead Neil Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPS OFFICER"}}],"security":"Common Stock","published_at":"2026-06-26T21:20:05.000Z","date":"2026-06-24","kind":"exercise","planned":true,"acquired":true,"shares":4922,"price":38.1,"value":187528.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025."}],"balance_after":65059,"source":{"system":"sec-edgar","filing":"0001578850-26-000017","document":"form4-06262026_050601.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885026000017/form4-06262026_050601.xml","form_type":"4"}},{"id":725823,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":30865,"kind":"person","name":"Almstead Neil Gregory","position":1,"cik":"0001578850","reported_name":"Almstead Neil Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPS OFFICER"}}],"security":"Common Stock","published_at":"2026-06-26T21:20:05.000Z","date":"2026-06-24","kind":"sale","planned":true,"acquired":false,"shares":401,"price":85.01,"value":34089.01,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $85.00 to $85.03 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":60137,"source":{"system":"sec-edgar","filing":"0001578850-26-000017","document":"form4-06262026_050601.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885026000017/form4-06262026_050601.xml","form_type":"4"}},{"id":725822,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":30865,"kind":"person","name":"Almstead Neil Gregory","position":1,"cik":"0001578850","reported_name":"Almstead Neil Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPS OFFICER"}}],"security":"Common Stock","published_at":"2026-06-26T21:20:05.000Z","date":"2026-06-24","kind":"exercise","planned":true,"acquired":true,"shares":401,"price":38.1,"value":15278.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025."}],"balance_after":60538,"source":{"system":"sec-edgar","filing":"0001578850-26-000017","document":"form4-06262026_050601.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885026000017/form4-06262026_050601.xml","form_type":"4"}},{"id":728100,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":30865,"kind":"person","name":"Almstead Neil Gregory","position":1,"cik":"0001578850","reported_name":"Almstead Neil Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPS OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-24T21:20:05.000Z","date":"2026-06-22","kind":"exercise","planned":true,"acquired":false,"shares":23749,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was granted on February 15, 2024, and vests over four years, with 25% of the shares underlying the option vesting on February 15, 2025, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on May 15, 2025."}],"balance_after":23751,"derivative":{"exercise_price":25.69,"expiration_date":"2034-02-14","underlying":"Common Stock","underlying_shares":23749},"source":{"system":"sec-edgar","filing":"0001578850-26-000014","document":"form4-06242026_050601.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885026000014/form4-06242026_050601.xml","form_type":"4"}},{"id":728099,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":30865,"kind":"person","name":"Almstead Neil Gregory","position":1,"cik":"0001578850","reported_name":"Almstead Neil Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPS OFFICER"}}],"security":"Common Stock","published_at":"2026-06-24T21:20:05.000Z","date":"2026-06-22","kind":"sale","planned":true,"acquired":false,"shares":11619,"price":81.21,"value":943578.99,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $81.00 to $81.57 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":60137,"source":{"system":"sec-edgar","filing":"0001578850-26-000014","document":"form4-06242026_050601.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885026000014/form4-06242026_050601.xml","form_type":"4"}},{"id":728098,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":30865,"kind":"person","name":"Almstead Neil Gregory","position":1,"cik":"0001578850","reported_name":"Almstead Neil Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPS OFFICER"}}],"security":"Common Stock","published_at":"2026-06-24T21:20:05.000Z","date":"2026-06-22","kind":"sale","planned":true,"acquired":false,"shares":12130,"price":80.61,"value":977799.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $80.00 to $80.99 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":71756,"source":{"system":"sec-edgar","filing":"0001578850-26-000014","document":"form4-06242026_050601.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885026000014/form4-06242026_050601.xml","form_type":"4"}},{"id":728097,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":30865,"kind":"person","name":"Almstead Neil Gregory","position":1,"cik":"0001578850","reported_name":"Almstead Neil Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPS OFFICER"}}],"security":"Common Stock","published_at":"2026-06-24T21:20:05.000Z","date":"2026-06-22","kind":"exercise","planned":true,"acquired":true,"shares":23749,"price":25.69,"value":610111.81,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025."}],"balance_after":83886,"source":{"system":"sec-edgar","filing":"0001578850-26-000014","document":"form4-06242026_050601.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885026000014/form4-06242026_050601.xml","form_type":"4"}},{"id":817441,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":30865,"kind":"person","name":"Almstead Neil Gregory","position":1,"cik":"0001578850","reported_name":"Almstead Neil Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPS OFFICER"}}],"security":"Common Stock","published_at":"2026-04-03T21:20:06.000Z","date":"2026-04-01","kind":"sale","planned":true,"acquired":false,"shares":80,"price":70.3,"value":5624.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025."}],"balance_after":60137,"source":{"system":"sec-edgar","filing":"0001578850-26-000012","document":"form4-04032026_050402.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885026000012/form4-04032026_050402.xml","form_type":"4"}},{"id":817440,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":30865,"kind":"person","name":"Almstead Neil Gregory","position":1,"cik":"0001578850","reported_name":"Almstead Neil Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPS OFFICER"}}],"security":"Common Stock","published_at":"2026-04-03T21:20:06.000Z","date":"2026-04-01","kind":"sale","planned":true,"acquired":false,"shares":12530,"price":69.5,"value":870835.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $69.26 to $70.13 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":60217,"source":{"system":"sec-edgar","filing":"0001578850-26-000012","document":"form4-04032026_050402.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885026000012/form4-04032026_050402.xml","form_type":"4"}},{"id":817439,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":30865,"kind":"person","name":"Almstead Neil Gregory","position":1,"cik":"0001578850","reported_name":"Almstead Neil Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPS OFFICER"}}],"security":"Common Stock","published_at":"2026-04-03T21:20:06.000Z","date":"2026-04-01","kind":"sale","planned":true,"acquired":false,"shares":39393,"price":68.89,"value":2713783.77,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $68.26 to $69.26 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":72747,"source":{"system":"sec-edgar","filing":"0001578850-26-000012","document":"form4-04032026_050402.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885026000012/form4-04032026_050402.xml","form_type":"4"}},{"id":854431,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":30865,"kind":"person","name":"Almstead Neil Gregory","position":1,"cik":"0001578850","reported_name":"Almstead Neil Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPS OFFICER"}}],"security":"Common Stock","published_at":"2026-03-09T21:20:05.000Z","date":"2026-03-05","kind":"sale","planned":true,"acquired":false,"shares":3989,"price":63.38,"value":252822.82,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 26, 2025."}],"balance_after":2737,"source":{"system":"sec-edgar","filing":"0001578850-26-000010","document":"form4-03092026_050301.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885026000010/form4-03092026_050301.xml","form_type":"4"}},{"id":891396,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":30865,"kind":"person","name":"Almstead Neil Gregory","position":1,"cik":"0001578850","reported_name":"Almstead Neil Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPS OFFICER"}}],"security":"Common Stock","published_at":"2026-02-20T22:20:05.000Z","date":"2026-02-18","kind":"sale","planned":true,"acquired":false,"shares":65,"price":69.36,"value":4508.4,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 217 RSUs from a February 15, 2024 grant of 870 RSUs."}],"balance_after":6726,"source":{"system":"sec-edgar","filing":"0001578850-26-000008","document":"form4-02202026_050201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885026000008/form4-02202026_050201.xml","form_type":"4"}},{"id":891395,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":30865,"kind":"person","name":"Almstead Neil Gregory","position":1,"cik":"0001578850","reported_name":"Almstead Neil Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPS OFFICER"}}],"security":"Common Stock","published_at":"2026-02-20T22:20:05.000Z","date":"2026-02-18","kind":"sale","planned":true,"acquired":false,"shares":3056,"price":69.36,"value":211964.16,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 4,750 RSUs from a February 15, 2024 grant of 19,000 RSUs and the vesting of 3,000 RSUs from a February 15, 2024 grant of 6,000 RSUs."}],"balance_after":112140,"source":{"system":"sec-edgar","filing":"0001578850-26-000008","document":"form4-02202026_050201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885026000008/form4-02202026_050201.xml","form_type":"4"}},{"id":941381,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":30865,"kind":"person","name":"Almstead Neil Gregory","position":1,"cik":"0001578850","reported_name":"Almstead Neil Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPS OFFICER"}}],"security":"Common Stock","published_at":"2026-01-12T22:20:06.000Z","date":"2026-01-08","kind":"sale","planned":true,"acquired":false,"shares":59,"price":76.45,"value":4510.55,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 195 RSUs from a January 7, 2022 grant of 780 RSUs."}],"balance_after":6791,"source":{"system":"sec-edgar","filing":"0001578850-26-000006","document":"form4-01122026_050101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885026000006/form4-01122026_050101.xml","form_type":"4"}},{"id":941380,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":30865,"kind":"person","name":"Almstead Neil Gregory","position":1,"cik":"0001578850","reported_name":"Almstead Neil Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPS OFFICER"}}],"security":"Common Stock","published_at":"2026-01-12T22:20:06.000Z","date":"2026-01-08","kind":"sale","planned":true,"acquired":false,"shares":881,"price":76.45,"value":67352.45,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 3,600 RSUs from a January 7, 2022 grant of 14,400 RSUs."}],"balance_after":115196,"source":{"system":"sec-edgar","filing":"0001578850-26-000006","document":"form4-01122026_050101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885026000006/form4-01122026_050101.xml","form_type":"4"}},{"id":943536,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":30865,"kind":"person","name":"Almstead Neil Gregory","position":1,"cik":"0001578850","reported_name":"Almstead Neil Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPS OFFICER"}}],"security":"Common Stock","published_at":"2026-01-08T22:20:05.000Z","date":"2026-01-07","kind":"sale","planned":true,"acquired":false,"shares":52,"price":77.48,"value":4028.96,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 177 RSUs from a January 5, 2023 grant of 710 RSUs."}],"balance_after":6850,"source":{"system":"sec-edgar","filing":"0001578850-26-000004","document":"form4-01082026_050101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885026000004/form4-01082026_050101.xml","form_type":"4"}},{"id":943535,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":30865,"kind":"person","name":"Almstead Neil Gregory","position":1,"cik":"0001578850","reported_name":"Almstead Neil Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPS OFFICER"}}],"security":"Common Stock","published_at":"2026-01-08T22:20:05.000Z","date":"2026-01-07","kind":"sale","planned":true,"acquired":false,"shares":1026,"price":77.48,"value":79494.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 4,250 RSUs from a January 5, 2023 grant of 17,000 RSUs."}],"balance_after":116077,"source":{"system":"sec-edgar","filing":"0001578850-26-000004","document":"form4-01082026_050101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885026000004/form4-01082026_050101.xml","form_type":"4"}},{"id":943534,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":30865,"kind":"person","name":"Almstead Neil Gregory","position":1,"cik":"0001578850","reported_name":"Almstead Neil Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPS OFFICER"}}],"security":"Common Stock","published_at":"2026-01-08T22:20:05.000Z","date":"2026-01-06","kind":"sale","planned":true,"acquired":false,"shares":54,"price":76.95,"value":4155.3,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 178 RSUs from a January 3, 2025 grant of 715 RSUs."}],"balance_after":6902,"source":{"system":"sec-edgar","filing":"0001578850-26-000004","document":"form4-01082026_050101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885026000004/form4-01082026_050101.xml","form_type":"4"}},{"id":943533,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":30865,"kind":"person","name":"Almstead Neil Gregory","position":1,"cik":"0001578850","reported_name":"Almstead Neil Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPS OFFICER"}}],"security":"Common Stock","published_at":"2026-01-08T22:20:05.000Z","date":"2026-01-06","kind":"sale","planned":true,"acquired":false,"shares":1279,"price":76.95,"value":98419.05,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 4,750 RSUs from a January 3, 2025 grant of 19,000 RSUs."}],"balance_after":117103,"source":{"system":"sec-edgar","filing":"0001578850-26-000004","document":"form4-01082026_050101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885026000004/form4-01082026_050101.xml","form_type":"4"}},{"id":947946,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":30865,"kind":"person","name":"Almstead Neil Gregory","position":1,"cik":"0001578850","reported_name":"Almstead Neil Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPS OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-06T22:20:35.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":43750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on January 2, 2026, and vests over four years, with 25% of the shares underlying the option vesting on January 2, 2027, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 2, 2027."}],"balance_after":43750,"derivative":{"exercise_price":76.74,"expiration_date":"2036-01-01","underlying":"Common Stock","underlying_shares":43750},"source":{"system":"sec-edgar","filing":"0001578850-26-000002","document":"form4-01062026_050126.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885026000002/form4-01062026_050126.xml","form_type":"4"}},{"id":947945,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":30865,"kind":"person","name":"Almstead Neil Gregory","position":1,"cik":"0001578850","reported_name":"Almstead Neil Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPS OFFICER"}}],"security":"Common Stock","published_at":"2026-01-06T22:20:35.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":520,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units granted on January 2, 2026 that vest in four equal installments over four years, commencing on January 2, 2027."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 257 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ended December 31, 2025."}],"balance_after":6956,"source":{"system":"sec-edgar","filing":"0001578850-26-000002","document":"form4-01062026_050126.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885026000002/form4-01062026_050126.xml","form_type":"4"}},{"id":947944,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":30865,"kind":"person","name":"Almstead Neil Gregory","position":1,"cik":"0001578850","reported_name":"Almstead Neil Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPS OFFICER"}}],"security":"Common Stock","published_at":"2026-01-06T22:20:35.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units granted on January 2, 2026 that vest in four equal installments over four years, commencing on January 2, 2027."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 257 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ended December 31, 2025."}],"balance_after":118382,"source":{"system":"sec-edgar","filing":"0001578850-26-000002","document":"form4-01062026_050126.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885026000002/form4-01062026_050126.xml","form_type":"4"}},{"id":987609,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":30865,"kind":"person","name":"Almstead Neil Gregory","position":1,"cik":"0001578850","reported_name":"Almstead Neil Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPS OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-11-26T22:25:06.000Z","date":"2025-11-25","kind":"exercise","planned":true,"acquired":false,"shares":11399,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 10, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F21","text":"Currently exercisable."}],"balance_after":0,"derivative":{"exercise_price":33.02,"expiration_date":"2029-01-21","underlying":"Common Stock","underlying_shares":11399},"source":{"system":"sec-edgar","filing":"0001578850-25-000007","document":"form4-11262025_051101.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":30,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885025000007/form4-11262025_051101.xml","form_type":"4"}},{"id":987608,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":30865,"kind":"person","name":"Almstead Neil Gregory","position":1,"cik":"0001578850","reported_name":"Almstead Neil Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPS OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-11-26T22:25:06.000Z","date":"2025-11-25","kind":"exercise","planned":true,"acquired":false,"shares":47624,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 10, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F21","text":"Currently exercisable."}],"balance_after":0,"derivative":{"exercise_price":33.02,"expiration_date":"2029-01-21","underlying":"Common Stock","underlying_shares":47624},"source":{"system":"sec-edgar","filing":"0001578850-25-000007","document":"form4-11262025_051101.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":29,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885025000007/form4-11262025_051101.xml","form_type":"4"}},{"id":987607,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":30865,"kind":"person","name":"Almstead Neil Gregory","position":1,"cik":"0001578850","reported_name":"Almstead Neil Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPS OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-11-26T22:25:06.000Z","date":"2025-11-25","kind":"exercise","planned":true,"acquired":false,"shares":8410,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 10, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F21","text":"Currently exercisable."}],"balance_after":0,"derivative":{"exercise_price":18.01,"expiration_date":"2028-01-02","underlying":"Common Stock","underlying_shares":8410},"source":{"system":"sec-edgar","filing":"0001578850-25-000007","document":"form4-11262025_051101.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":28,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885025000007/form4-11262025_051101.xml","form_type":"4"}},{"id":987606,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":30865,"kind":"person","name":"Almstead Neil Gregory","position":1,"cik":"0001578850","reported_name":"Almstead Neil Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPS OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-11-26T22:25:06.000Z","date":"2025-11-25","kind":"exercise","planned":true,"acquired":false,"shares":2020,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 10, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F21","text":"Currently exercisable."}],"balance_after":47624,"derivative":{"exercise_price":33.02,"expiration_date":"2029-01-21","underlying":"Common Stock","underlying_shares":2020},"source":{"system":"sec-edgar","filing":"0001578850-25-000007","document":"form4-11262025_051101.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":27,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885025000007/form4-11262025_051101.xml","form_type":"4"}},{"id":987605,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":30865,"kind":"person","name":"Almstead Neil Gregory","position":1,"cik":"0001578850","reported_name":"Almstead Neil Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPS OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-11-26T22:25:06.000Z","date":"2025-11-25","kind":"exercise","planned":true,"acquired":false,"shares":2475,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 10, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F21","text":"Currently exercisable."}],"balance_after":8410,"derivative":{"exercise_price":18.01,"expiration_date":"2028-01-02","underlying":"Common Stock","underlying_shares":2475},"source":{"system":"sec-edgar","filing":"0001578850-25-000007","document":"form4-11262025_051101.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":26,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885025000007/form4-11262025_051101.xml","form_type":"4"}},{"id":987604,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":30865,"kind":"person","name":"Almstead Neil Gregory","position":1,"cik":"0001578850","reported_name":"Almstead Neil Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPS OFFICER"}}],"security":"Common Stock","published_at":"2025-11-26T22:25:06.000Z","date":"2025-11-25","kind":"sale","planned":true,"acquired":false,"shares":200,"price":85.34,"value":17068.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 10, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F20","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $85.33 to $85.34 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":100625,"source":{"system":"sec-edgar","filing":"0001578850-25-000007","document":"form4-11262025_051101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":24,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885025000007/form4-11262025_051101.xml","form_type":"4"}},{"id":987603,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":30865,"kind":"person","name":"Almstead Neil Gregory","position":1,"cik":"0001578850","reported_name":"Almstead Neil Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPS OFFICER"}}],"security":"Common Stock","published_at":"2025-11-26T22:25:06.000Z","date":"2025-11-25","kind":"sale","planned":true,"acquired":false,"shares":2621,"price":84.54,"value":221579.34,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 10, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F19","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $84.00 to $84.97 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":100825,"source":{"system":"sec-edgar","filing":"0001578850-25-000007","document":"form4-11262025_051101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":23,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885025000007/form4-11262025_051101.xml","form_type":"4"}},{"id":987602,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":30865,"kind":"person","name":"Almstead Neil Gregory","position":1,"cik":"0001578850","reported_name":"Almstead Neil Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPS OFFICER"}}],"security":"Common Stock","published_at":"2025-11-26T22:25:06.000Z","date":"2025-11-25","kind":"sale","planned":true,"acquired":false,"shares":4834,"price":83.39,"value":403107.26,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 10, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F18","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $83.00 to $83.94 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":103446,"source":{"system":"sec-edgar","filing":"0001578850-25-000007","document":"form4-11262025_051101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":22,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885025000007/form4-11262025_051101.xml","form_type":"4"}},{"id":987601,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":30865,"kind":"person","name":"Almstead Neil Gregory","position":1,"cik":"0001578850","reported_name":"Almstead Neil Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPS OFFICER"}}],"security":"Common Stock","published_at":"2025-11-26T22:25:06.000Z","date":"2025-11-25","kind":"sale","planned":true,"acquired":false,"shares":3744,"price":82.61,"value":309291.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 10, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F17","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $82.00 to $82.99 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":108280,"source":{"system":"sec-edgar","filing":"0001578850-25-000007","document":"form4-11262025_051101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885025000007/form4-11262025_051101.xml","form_type":"4"}},{"id":987600,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":30865,"kind":"person","name":"Almstead Neil Gregory","position":1,"cik":"0001578850","reported_name":"Almstead Neil Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPS OFFICER"}}],"security":"Common Stock","published_at":"2025-11-26T22:25:06.000Z","date":"2025-11-25","kind":"exercise","planned":true,"acquired":true,"shares":11399,"price":33.02,"value":376394.98,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 10, 2024."}],"balance_after":112024,"source":{"system":"sec-edgar","filing":"0001578850-25-000007","document":"form4-11262025_051101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885025000007/form4-11262025_051101.xml","form_type":"4"}},{"id":987599,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":30865,"kind":"person","name":"Almstead Neil Gregory","position":1,"cik":"0001578850","reported_name":"Almstead Neil Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPS OFFICER"}}],"security":"Common Stock","published_at":"2025-11-26T22:25:06.000Z","date":"2025-11-25","kind":"sale","planned":true,"acquired":false,"shares":3095,"price":85.15,"value":263539.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 10, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F16","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $85.00 to $85.37 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":100625,"source":{"system":"sec-edgar","filing":"0001578850-25-000007","document":"form4-11262025_051101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885025000007/form4-11262025_051101.xml","form_type":"4"}},{"id":987598,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":30865,"kind":"person","name":"Almstead Neil Gregory","position":1,"cik":"0001578850","reported_name":"Almstead Neil Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPS OFFICER"}}],"security":"Common Stock","published_at":"2025-11-26T22:25:06.000Z","date":"2025-11-25","kind":"sale","planned":true,"acquired":false,"shares":9171,"price":84.42,"value":774215.82,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 10, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F15","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $83.95 to $84.92 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":103720,"source":{"system":"sec-edgar","filing":"0001578850-25-000007","document":"form4-11262025_051101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885025000007/form4-11262025_051101.xml","form_type":"4"}},{"id":987597,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":30865,"kind":"person","name":"Almstead Neil Gregory","position":1,"cik":"0001578850","reported_name":"Almstead Neil Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPS OFFICER"}}],"security":"Common Stock","published_at":"2025-11-26T22:25:06.000Z","date":"2025-11-25","kind":"sale","planned":true,"acquired":false,"shares":21844,"price":83.33,"value":1820260.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 10, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F14","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $82.95 to $83.94 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":112891,"source":{"system":"sec-edgar","filing":"0001578850-25-000007","document":"form4-11262025_051101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885025000007/form4-11262025_051101.xml","form_type":"4"}},{"id":987596,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":30865,"kind":"person","name":"Almstead Neil Gregory","position":1,"cik":"0001578850","reported_name":"Almstead Neil Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPS OFFICER"}}],"security":"Common Stock","published_at":"2025-11-26T22:25:06.000Z","date":"2025-11-25","kind":"sale","planned":true,"acquired":false,"shares":13514,"price":82.55,"value":1115580.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 10, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F13","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $81.85 to $82.94 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":134735,"source":{"system":"sec-edgar","filing":"0001578850-25-000007","document":"form4-11262025_051101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885025000007/form4-11262025_051101.xml","form_type":"4"}},{"id":987595,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":30865,"kind":"person","name":"Almstead Neil Gregory","position":1,"cik":"0001578850","reported_name":"Almstead Neil Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPS OFFICER"}}],"security":"Common Stock","published_at":"2025-11-26T22:25:06.000Z","date":"2025-11-25","kind":"exercise","planned":true,"acquired":true,"shares":47624,"price":33.02,"value":1572544.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 10, 2024."}],"balance_after":148249,"source":{"system":"sec-edgar","filing":"0001578850-25-000007","document":"form4-11262025_051101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885025000007/form4-11262025_051101.xml","form_type":"4"}},{"id":987594,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":30865,"kind":"person","name":"Almstead Neil Gregory","position":1,"cik":"0001578850","reported_name":"Almstead Neil Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPS OFFICER"}}],"security":"Common Stock","published_at":"2025-11-26T22:25:06.000Z","date":"2025-11-25","kind":"sale","planned":true,"acquired":false,"shares":200,"price":85.37,"value":17074.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 10, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F12","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $85.33 to $85.41 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":100625,"source":{"system":"sec-edgar","filing":"0001578850-25-000007","document":"form4-11262025_051101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885025000007/form4-11262025_051101.xml","form_type":"4"}},{"id":987593,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":30865,"kind":"person","name":"Almstead Neil Gregory","position":1,"cik":"0001578850","reported_name":"Almstead Neil Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPS OFFICER"}}],"security":"Common Stock","published_at":"2025-11-26T22:25:06.000Z","date":"2025-11-25","kind":"sale","planned":true,"acquired":false,"shares":1757,"price":84.56,"value":148571.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 10, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $84.00 to $84.83 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":100825,"source":{"system":"sec-edgar","filing":"0001578850-25-000007","document":"form4-11262025_051101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885025000007/form4-11262025_051101.xml","form_type":"4"}},{"id":987592,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":30865,"kind":"person","name":"Almstead Neil Gregory","position":1,"cik":"0001578850","reported_name":"Almstead Neil Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPS OFFICER"}}],"security":"Common Stock","published_at":"2025-11-26T22:25:06.000Z","date":"2025-11-25","kind":"sale","planned":true,"acquired":false,"shares":3663,"price":83.41,"value":305530.83,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 10, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $83.00 to $83.97 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":102582,"source":{"system":"sec-edgar","filing":"0001578850-25-000007","document":"form4-11262025_051101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885025000007/form4-11262025_051101.xml","form_type":"4"}},{"id":987591,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":30865,"kind":"person","name":"Almstead Neil Gregory","position":1,"cik":"0001578850","reported_name":"Almstead Neil Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPS OFFICER"}}],"security":"Common Stock","published_at":"2025-11-26T22:25:06.000Z","date":"2025-11-25","kind":"sale","planned":true,"acquired":false,"shares":2790,"price":82.82,"value":231067.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 10, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $82.00 to $82.99 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":106245,"source":{"system":"sec-edgar","filing":"0001578850-25-000007","document":"form4-11262025_051101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885025000007/form4-11262025_051101.xml","form_type":"4"}},{"id":987590,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":30865,"kind":"person","name":"Almstead Neil Gregory","position":1,"cik":"0001578850","reported_name":"Almstead Neil Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPS OFFICER"}}],"security":"Common Stock","published_at":"2025-11-26T22:25:06.000Z","date":"2025-11-25","kind":"exercise","planned":true,"acquired":true,"shares":8410,"price":18.01,"value":151464.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 10, 2024."}],"balance_after":109035,"source":{"system":"sec-edgar","filing":"0001578850-25-000007","document":"form4-11262025_051101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885025000007/form4-11262025_051101.xml","form_type":"4"}},{"id":987589,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":30865,"kind":"person","name":"Almstead Neil Gregory","position":1,"cik":"0001578850","reported_name":"Almstead Neil Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPS OFFICER"}}],"security":"Common Stock","published_at":"2025-11-26T22:25:06.000Z","date":"2025-11-25","kind":"sale","planned":true,"acquired":false,"shares":180,"price":85.17,"value":15330.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 10, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $85.16 to $85.17 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":100625,"source":{"system":"sec-edgar","filing":"0001578850-25-000007","document":"form4-11262025_051101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885025000007/form4-11262025_051101.xml","form_type":"4"}},{"id":987588,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":30865,"kind":"person","name":"Almstead Neil Gregory","position":1,"cik":"0001578850","reported_name":"Almstead Neil Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPS OFFICER"}}],"security":"Common Stock","published_at":"2025-11-26T22:25:06.000Z","date":"2025-11-25","kind":"sale","planned":true,"acquired":false,"shares":289,"price":84.61,"value":24452.29,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 10, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $84.00 to $84.97 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":100805,"source":{"system":"sec-edgar","filing":"0001578850-25-000007","document":"form4-11262025_051101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885025000007/form4-11262025_051101.xml","form_type":"4"}},{"id":987587,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":30865,"kind":"person","name":"Almstead Neil Gregory","position":1,"cik":"0001578850","reported_name":"Almstead Neil Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPS OFFICER"}}],"security":"Common Stock","published_at":"2025-11-26T22:25:06.000Z","date":"2025-11-25","kind":"sale","planned":true,"acquired":false,"shares":862,"price":83.35,"value":71847.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 10, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $83.00 to $83.96 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":101094,"source":{"system":"sec-edgar","filing":"0001578850-25-000007","document":"form4-11262025_051101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885025000007/form4-11262025_051101.xml","form_type":"4"}},{"id":987586,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":30865,"kind":"person","name":"Almstead Neil Gregory","position":1,"cik":"0001578850","reported_name":"Almstead Neil Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPS OFFICER"}}],"security":"Common Stock","published_at":"2025-11-26T22:25:06.000Z","date":"2025-11-25","kind":"sale","planned":true,"acquired":false,"shares":689,"price":82.63,"value":56932.07,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 10, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $82.00 to $82.98 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":101956,"source":{"system":"sec-edgar","filing":"0001578850-25-000007","document":"form4-11262025_051101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885025000007/form4-11262025_051101.xml","form_type":"4"}},{"id":987585,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":30865,"kind":"person","name":"Almstead Neil Gregory","position":1,"cik":"0001578850","reported_name":"Almstead Neil Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPS OFFICER"}}],"security":"Common Stock","published_at":"2025-11-26T22:25:06.000Z","date":"2025-11-25","kind":"exercise","planned":true,"acquired":true,"shares":2020,"price":33.02,"value":66700.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 10, 2024."}],"balance_after":102645,"source":{"system":"sec-edgar","filing":"0001578850-25-000007","document":"form4-11262025_051101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885025000007/form4-11262025_051101.xml","form_type":"4"}},{"id":987584,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":30865,"kind":"person","name":"Almstead Neil Gregory","position":1,"cik":"0001578850","reported_name":"Almstead Neil Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPS OFFICER"}}],"security":"Common Stock","published_at":"2025-11-26T22:25:06.000Z","date":"2025-11-25","kind":"sale","planned":true,"acquired":false,"shares":574,"price":84.67,"value":48600.58,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 10, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $84.00 to $84.97 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":100625,"source":{"system":"sec-edgar","filing":"0001578850-25-000007","document":"form4-11262025_051101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885025000007/form4-11262025_051101.xml","form_type":"4"}},{"id":987583,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":30865,"kind":"person","name":"Almstead Neil Gregory","position":1,"cik":"0001578850","reported_name":"Almstead Neil Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPS OFFICER"}}],"security":"Common Stock","published_at":"2025-11-26T22:25:06.000Z","date":"2025-11-25","kind":"sale","planned":true,"acquired":false,"shares":990,"price":83.44,"value":82605.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 10, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $83.00 to $83.96 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":101199,"source":{"system":"sec-edgar","filing":"0001578850-25-000007","document":"form4-11262025_051101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885025000007/form4-11262025_051101.xml","form_type":"4"}},{"id":987582,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":30865,"kind":"person","name":"Almstead Neil Gregory","position":1,"cik":"0001578850","reported_name":"Almstead Neil Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPS OFFICER"}}],"security":"Common Stock","published_at":"2025-11-26T22:25:06.000Z","date":"2025-11-25","kind":"sale","planned":true,"acquired":false,"shares":911,"price":82.63,"value":75275.93,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 10, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $82.00 to $82.98 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":102189,"source":{"system":"sec-edgar","filing":"0001578850-25-000007","document":"form4-11262025_051101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885025000007/form4-11262025_051101.xml","form_type":"4"}},{"id":987581,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":30865,"kind":"person","name":"Almstead Neil Gregory","position":1,"cik":"0001578850","reported_name":"Almstead Neil Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPS OFFICER"}}],"security":"Common Stock","published_at":"2025-11-26T22:25:06.000Z","date":"2025-11-25","kind":"exercise","planned":true,"acquired":true,"shares":2475,"price":18.01,"value":44574.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 10, 2024."}],"balance_after":103100,"source":{"system":"sec-edgar","filing":"0001578850-25-000007","document":"form4-11262025_051101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885025000007/form4-11262025_051101.xml","form_type":"4"}},{"id":987624,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":30865,"kind":"person","name":"Almstead Neil Gregory","position":1,"cik":"0001578850","reported_name":"Almstead Neil Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPS OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-11-26T22:20:07.000Z","date":"2025-11-24","kind":"exercise","planned":true,"acquired":false,"shares":6101,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 10, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Currently exercisable."}],"balance_after":11399,"derivative":{"exercise_price":33.02,"expiration_date":"2029-01-21","underlying":"Common Stock","underlying_shares":6101},"source":{"system":"sec-edgar","filing":"0001578850-25-000006","document":"form4-11262025_051103.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885025000006/form4-11262025_051103.xml","form_type":"4"}},{"id":987623,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":30865,"kind":"person","name":"Almstead Neil Gregory","position":1,"cik":"0001578850","reported_name":"Almstead Neil Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPS OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-11-26T22:20:07.000Z","date":"2025-11-24","kind":"exercise","planned":true,"acquired":false,"shares":21206,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 10, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Currently exercisable."}],"balance_after":49644,"derivative":{"exercise_price":33.02,"expiration_date":"2029-01-21","underlying":"Common Stock","underlying_shares":21206},"source":{"system":"sec-edgar","filing":"0001578850-25-000006","document":"form4-11262025_051103.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885025000006/form4-11262025_051103.xml","form_type":"4"}},{"id":987622,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":30865,"kind":"person","name":"Almstead Neil Gregory","position":1,"cik":"0001578850","reported_name":"Almstead Neil Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPS OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-11-26T22:20:07.000Z","date":"2025-11-24","kind":"exercise","planned":true,"acquired":false,"shares":4715,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 10, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Currently exercisable."}],"balance_after":10885,"derivative":{"exercise_price":18.01,"expiration_date":"2028-01-02","underlying":"Common Stock","underlying_shares":4715},"source":{"system":"sec-edgar","filing":"0001578850-25-000006","document":"form4-11262025_051103.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885025000006/form4-11262025_051103.xml","form_type":"4"}},{"id":987621,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":30865,"kind":"person","name":"Almstead Neil Gregory","position":1,"cik":"0001578850","reported_name":"Almstead Neil Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPS OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-11-26T22:20:07.000Z","date":"2025-11-24","kind":"exercise","planned":true,"acquired":false,"shares":1650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 10, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Currently exercisable."}],"balance_after":70850,"derivative":{"exercise_price":33.02,"expiration_date":"2029-01-21","underlying":"Common Stock","underlying_shares":1650},"source":{"system":"sec-edgar","filing":"0001578850-25-000006","document":"form4-11262025_051103.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885025000006/form4-11262025_051103.xml","form_type":"4"}},{"id":987620,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":30865,"kind":"person","name":"Almstead Neil Gregory","position":1,"cik":"0001578850","reported_name":"Almstead Neil Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPS OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-11-26T22:20:07.000Z","date":"2025-11-24","kind":"exercise","planned":true,"acquired":false,"shares":1900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 10, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Currently exercisable."}],"balance_after":15600,"derivative":{"exercise_price":18.01,"expiration_date":"2028-01-02","underlying":"Common Stock","underlying_shares":1900},"source":{"system":"sec-edgar","filing":"0001578850-25-000006","document":"form4-11262025_051103.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885025000006/form4-11262025_051103.xml","form_type":"4"}},{"id":987619,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":30865,"kind":"person","name":"Almstead Neil Gregory","position":1,"cik":"0001578850","reported_name":"Almstead Neil Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPS OFFICER"}}],"security":"Common Stock","published_at":"2025-11-26T22:20:07.000Z","date":"2025-11-24","kind":"sale","planned":true,"acquired":false,"shares":6101,"price":80.17,"value":489117.17,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 10, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $80.00 to $80.56 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":100625,"source":{"system":"sec-edgar","filing":"0001578850-25-000006","document":"form4-11262025_051103.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885025000006/form4-11262025_051103.xml","form_type":"4"}},{"id":987618,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":30865,"kind":"person","name":"Almstead Neil Gregory","position":1,"cik":"0001578850","reported_name":"Almstead Neil Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPS OFFICER"}}],"security":"Common Stock","published_at":"2025-11-26T22:20:07.000Z","date":"2025-11-24","kind":"exercise","planned":true,"acquired":true,"shares":6101,"price":33.02,"value":201455.02,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 10, 2024."}],"balance_after":106726,"source":{"system":"sec-edgar","filing":"0001578850-25-000006","document":"form4-11262025_051103.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885025000006/form4-11262025_051103.xml","form_type":"4"}},{"id":987617,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":30865,"kind":"person","name":"Almstead Neil Gregory","position":1,"cik":"0001578850","reported_name":"Almstead Neil Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPS OFFICER"}}],"security":"Common Stock","published_at":"2025-11-26T22:20:07.000Z","date":"2025-11-24","kind":"sale","planned":true,"acquired":false,"shares":21206,"price":80.19,"value":1700509.14,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 10, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $80.00 to $80.88 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":100625,"source":{"system":"sec-edgar","filing":"0001578850-25-000006","document":"form4-11262025_051103.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885025000006/form4-11262025_051103.xml","form_type":"4"}},{"id":987616,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":30865,"kind":"person","name":"Almstead Neil Gregory","position":1,"cik":"0001578850","reported_name":"Almstead Neil Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPS OFFICER"}}],"security":"Common Stock","published_at":"2025-11-26T22:20:07.000Z","date":"2025-11-24","kind":"exercise","planned":true,"acquired":true,"shares":21206,"price":33.02,"value":700222.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 10, 2024."}],"balance_after":121831,"source":{"system":"sec-edgar","filing":"0001578850-25-000006","document":"form4-11262025_051103.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885025000006/form4-11262025_051103.xml","form_type":"4"}},{"id":987615,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":30865,"kind":"person","name":"Almstead Neil Gregory","position":1,"cik":"0001578850","reported_name":"Almstead Neil Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPS OFFICER"}}],"security":"Common Stock","published_at":"2025-11-26T22:20:07.000Z","date":"2025-11-24","kind":"sale","planned":true,"acquired":false,"shares":4715,"price":80.15,"value":377907.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 10, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $80.00 to $80.68 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":100625,"source":{"system":"sec-edgar","filing":"0001578850-25-000006","document":"form4-11262025_051103.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885025000006/form4-11262025_051103.xml","form_type":"4"}}],"next_cursor":"2025-11-26T22:20:07.000000Z,987615"}